Clemastine
- Generic Name
- Clemastine
- Brand Names
- Wal-hist 12 Hr Relief
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26ClNO
- CAS Number
- 15686-51-8
- Unique Ingredient Identifier
- 95QN29S1ID
Overview
An ethanolamine-derivative, first generation histamine H1 antagonist used in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness.
Background
An ethanolamine-derivative, first generation histamine H1 antagonist used in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness.
Indication
For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation. Also for the management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Used as self-medication for temporary relief of symptoms associated with the common cold.
Associated Conditions
- Allergic Rhinitis (AR)
- Angioedema
- Common Cold
- Urticaria
Clinical Trials
FDA Approved Products
CLEMASTINE FUMARATE
Manufacturer:Chartwell RX, LLC
Route:ORAL
Strength:0.67 mg in 5 mL
Approved: 2023/07/07
NDC:62135-713
Clemastine Fumarate
Manufacturer:Teva Pharmaceuticals USA, Inc.
Route:ORAL
Strength:2.68 mg in 1 1
Approved: 2021/08/14
NDC:0093-0308
Clemastine Fumarate
Manufacturer:Northwind Pharmaceuticals, LLC
Route:Oral
Strength:2.68 mg in 1 1
Approved: 2014/07/21
NDC:51655-425
Clemastine Fumarate
Manufacturer:Ayurax, LLC
Route:ORAL
Strength:0.67 mg in 5 mL
Approved: 2021/03/04
NDC:73308-358
CLEMASZ
Manufacturer:New HeightsRx, LLC
Route:ORAL
Strength:2.68 mg in 1 1
Approved: 2025/05/03
NDC:84044-268
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath